State of the Art of Biochemical Markers in Metastatic Bone Disease and the Role of Bisphosphonates as Therapeutic Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-676x|1|3|225-241

ISSN： 1573-4129

Source： Current Pharmaceutical Analysis, Vol.1, Iss.3, 2005-11, pp. : 225-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biochemical Markers of Bone Turnover in the Clinical Development of Drugs for Osteoporosis and Metastatic Bone Disease: Potential Uses and Pitfalls

By Cremers Serge   Garnero Patrick  

Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. : 2031-2058

Adis International

Access to resources Recommend Favorite

Pathophysiology of Metastatic Bone Disease and the Role of the Second Generation of Bisphosphonates: From Basic Science to Medicine

By  

Current Pharmaceutical Design, Vol. 22, Iss. 11, 2016-03 ,pp. : 1546-1557

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease

By Dawson Nancy A  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 705-716

Informa Healthcare

Access to resources Recommend Favorite

Combined Therapies of Bone Disease with Bisphosphonates

By  

Current Pharmaceutical Design, Vol. 16, Iss. 27, 2010-09 ,pp. : 2988-2997

Bentham Science Publishers

Access to resources Recommend Favorite

Bone Metastatic Disease: Taking Aim at New Therapeutic Targets

By  

Current Medicinal Chemistry, Vol. 18, Iss. 20, 2011-07 ,pp. : 3093-3115

Bentham Science Publishers

Access to resources Recommend Favorite